SCHW
53
-11
CVX
23
-2
FDX
34
-2
NUE
39
-4
EMC
71
3
VMC
48
-2
BWA
49
-6
K
50
-3
KMX
66
-2
MCO
74
-3
PYPL
62
2
NWS
52
-4
KHC
22
2
HUM
33
2
VZ
39
2
AN
50
-5
O
19
-12
AIZ
66
-2
GOOG
81
-2
CSCO
61
-3
SCHW
53
-11
CVX
23
-2
FDX
34
-2
NUE
39
-4
EMC
71
3
VMC
48
-2
BWA
49
-6
K
50
-3
KMX
66
-2
MCO
74
-3
PYPL
62
2
NWS
52
-4
KHC
22
2
HUM
33
2
VZ
39
2
AN
50
-5
O
19
-12
AIZ
66
-2
GOOG
81
-2
CSCO
61
-3
Financhill
Back

Ginkgo Bioworks Holdings Vs. Corvus Pharmaceuticals Industry Stock Comparison

Sell
45

DNA
Ginkgo Bioworks Holdings

Last Price:
9.44
Seasonality Move:
-37.29%
Sell
40

CRVS
Corvus Pharmaceuticals

Last Price:
7.37
Seasonality Move:
-20.35%
Sell
45
Ginkgo Bioworks Holdings (DNA) is a Sell

Is Ginkgo Bioworks Holdings a Buy, Sell or Hold?

  • The current Ginkgo Bioworks Holdings [DNA] share price is $9.44. The Score for DNA is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • DNA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Corvus Pharmaceuticals (CRVS) is a Sell

Is Corvus Pharmaceuticals a Buy, Sell or Hold?

  • The current Corvus Pharmaceuticals [CRVS] share price is $7.38. The Score for CRVS is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • CRVS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DNA Stock Price Chart

What is Ginkgo Bioworks Holdings's stock price today?

  • The Ginkgo Bioworks Holdings share price today is $9.44
    The current trend is moderately bullish and DNA is experiencing selling pressure, which indicates risk of future bearish movement.

CRVS Stock Price Chart

What is Corvus Pharmaceuticals's stock price today?

  • The Corvus Pharmaceuticals share price today is $7.38
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRVS is experiencing selling pressure, which indicates risk of future bearish movement.

DNA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.7 Buy
Relative Strength Index (14 RSI): 52.26 Buy
Chaikin Money Flow: -1056113 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.11 - 10.27) Buy
Bollinger Bands (100): (6.57 - 10.81) Buy

CRVS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 37.38 Sell
Chaikin Money Flow: -1384142 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8 - 9.04) Sell
Bollinger Bands (100): (3.9 - 8.28) Buy

DNA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.49 Sell
20-day SMA: 8.78 Buy
50-day SMA: 8.41 Buy
200-day SMA: 19.42 Sell
8-day EMA: 10.1 Sell
20-day EMA: 9.38 Buy
50-day EMA: 8.89 Buy
200-day EMA: 20.54 Sell

CRVS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.02 Sell
20-day SMA: 8.4 Sell
50-day SMA: 8.01 Sell
200-day SMA: 4 Buy
8-day EMA: 8.02 Sell
20-day EMA: 8.25 Sell
50-day EMA: 7.73 Sell
200-day EMA: 4.9 Buy

Ginkgo Bioworks Holdings Earnings Growth & DNA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $3.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $16.47 per share, and an increase next year of $0.03 per share.

Corvus Pharmaceuticals Earnings Growth & CRVS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and an increase next year of $0.46 per share.

Ginkgo Bioworks Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Corvus Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):